ofloxacin has been researched along with minocycline in 115 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.61) | 18.7374 |
1990's | 33 (28.70) | 18.2507 |
2000's | 51 (44.35) | 29.6817 |
2010's | 26 (22.61) | 24.3611 |
2020's | 2 (1.74) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
Avdeef, A; Sun, N; Tam, KY; Tsinman, O | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
Grosset, JH; Ji, B; Perani, EG; Petinon, C | 1 |
Dailloux, M; Villemain, P | 1 |
Hondou, T; Sugase, M; Yajima, H | 1 |
Kobayashi, M; Mashimo, T; Miki, M; Nakata, S; Okabe, K; Onuki, T; Takahashi, O; Yamanaka, H | 1 |
Dekio, S; Itagaki, A; Kato, Y; Nishio, T; Oka, N; Uchida, T; Uchiyama, T | 1 |
Fujioka, T; Hayashi, Y; Ito, G; Kato, M; Kuroki, H; Matsuura, T; Miyake, T; Takeuchi, T; Yamada, Y; Yamamoto, K | 1 |
Nagayama, A; Nakao, T; Taen, H | 1 |
Konno, M | 1 |
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S | 1 |
Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K | 1 |
Akamatsu, H; Akamatsu, M; Asada, Y; Kurokawa, I; Nishijima, S | 1 |
Bébéar, C; de Barbeyrac, B; Dewilde, A; Edert, D; Janvresse, C; Layani, MP; Le Faou, A; Lefèvre, JC; Mendel, I; Renaudin, H | 1 |
Nakashima, T; Ohkawa, M; Shoda, R; Tokunaga, S; Yamaguchi, K | 1 |
Asada, Y; Mitsuya, K; Namura, S; Nishijima, S | 1 |
Grosset, JH; Ji, B; Perani, EG; Petinom, C | 1 |
Grosset, JH; Jamet, P; Ji, B; Lienhardt, C; Perani, EG; Petinon, C; Sow, S | 1 |
Kubota, Y; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y | 1 |
Chang, JC; Ho, SW; Hsieh, WC; Hsueh, PR; Luh, KT; Wu, JJ | 1 |
Cartel, JL; Grosset, JH; Mane, I | 1 |
Lockwood, DN | 1 |
Matsuoka, M | 1 |
Bhattacharya, SN; Jain, S; Kumar, S; Sehgal, VN | 1 |
Feliciano, AE; Hennenfent, BR | 1 |
Diderot, V; Grosset, J; Ji, B; Lienhardt, C; Perani, E; Sow, S | 1 |
Ramu, G | 1 |
Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
Franzblau, S; Grosset, JH | 1 |
Ganapati, R; Kingsley, S; Pai, VV; Revankar, CR | 1 |
Bulchand, HO; Ganapati, R; Pai, VV; Revankar, CR | 2 |
Ganapati, R; Pai, VV; Revankar, CR; Samy, MS | 1 |
Ebenezer, GJ; Job, CK | 1 |
Diletto, C | 1 |
Daulako, EC | 1 |
Tin, K | 1 |
Grillone, S; Pattyn, S | 1 |
Matsumoto, A; Matsushima, T; Miyashita, N | 1 |
Hatakeyama, S; Oka, T; Suzuki, K; Tachibana, A; Tateda, K; Yamaguchi, K | 1 |
Chauhan, DS; Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Sharma, RK; Sharma, VD; Singh, D; Singh, HB; Srivastava, K | 1 |
Blanc, L; Diletto, C; Levy, L | 1 |
Gupte, MD | 1 |
Andrade, AL; Costa, MB; Gillis, TP; Gomes, MK; Krahenbuhl, JL; Maroclo, AL; Martelli, CM; Narahashi, K; Nery, JA; Peninni, S; Rebello, PF; Sacchetim, SC; Salles, AM; Silva, SA; Stefani, MM | 1 |
Biswas, SK; Hajra, SK; Majumder, V; Saha, B; Saha, K | 1 |
Ganapati, R; Khopkar, U; Pai, VV; Shinde, A | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Antia, NH; Bulchand, HO; Ganapati, R; Pai, VV; Revenker, CR; Shetty, VP; Wakade, AV | 1 |
Reddy, R; Suneetha, S | 1 |
Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
Cavalcanti Neto, PF; Costa, MB; Gomes, MK; Maceira, JP; Martelli, CM; Narahashi, K; Pignataro, PE; Rebello, PF; Schettini, AP; Scollard, DM; Stefani, MM; Ueda, ES | 1 |
Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY | 1 |
Hata, K; Hisamori, S; Inoue, T; Ishimaru, H; Katoh, K; Maeda, Y; Maniwa, K; Minaguchi, M; Oida, K; Sakuramoto, M; Taguchi, Y; Tanaka, E; Terada, K | 1 |
Asaumi, N; Kiguchi, T; Masuda, K; Niiya, K; Niiya, M; Tanimoto, M; Yoshida, C | 1 |
Huang, C; Li, J; Lin, N; Liu, Z; Tu, Y; Zhang, D | 1 |
Gillis, TP; Krahenbuhl, JL; Martelli, CM; Stefani, MM | 1 |
Asaumi, N; Niiya, K; Niiya, M; Shibakura, M; Tanimoto, M; Yoshida, C | 1 |
Inoue, K; Kumakura, S; Tsutsui, T; Uchida, M | 1 |
Abalos, RM; Balagon, MV; Cellona, RV; Dela Cruz, EC; Fajardo, TT; Tan, EV; Villahermosa, LG; Walsh, DS; Walsh, GP | 1 |
Dave, S; Jayanthi, S; Nori, AV; Thappa, DM | 1 |
Bormann, G; Marsch, WC | 1 |
Fujimoto, Y; Komeda, H; Takada, T; Uno, M; Yamada, Y | 1 |
Biswas, SK | 1 |
Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
Arakawa, Y; Arashima, Y; Ikeda, T; Iwakami, E; Kato, K; Komiya, T; Matsukawa, Y; Oshida, S | 1 |
Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Singh, HB | 1 |
Ishihara, K; Kato, T; Kimizuka, R; Okuda, K; Takahashi, N | 1 |
Garrison, MW; Nuemiller, JJ | 1 |
Shinagawa, N; Takeyama, H; Taniguchi, M; Yura, J | 1 |
Ishikawa, M; Ozaki, M | 1 |
Costa, MB; Gillis, TP; Gomes, MK; Krahenbuhl, JL; Martelli, CM; Narahashi, K; Pereira, GA; Rebello, PF; Sousa, AL; Stefani, MM | 1 |
Gyi, MM; Han, TT; Myint, K; Oo, KN; Wai, KT; Yin, NN | 1 |
Dowzicky, M; Kuti, JL; Nicolau, DP | 1 |
May, T | 1 |
Arita, K; Kodama, K; Moriuchi, R; Shimizu, H; Shimizu, T; Ujiie, H | 1 |
Bergallo, C; Cooper, CA; Dartois, N; Dukart, G; Gandjini, H; Jasovich, A; Mallick, R; Oliva, ME; Tanaseanu, C; Teglia, O | 1 |
Gea-Banacloche, JC; Green, O; Murray, P | 1 |
Bergallo, C; Cooper, A; de Wouters, L; Dukart, G; Jasovich, A; Lentnek, A; Mallick, R; Oliva, ME; Teglia, O; Zlocowski, JC | 1 |
Castaing, N; Cooper, A; Dartois, N; Gandjini, H | 1 |
Dogru, M; Ibrahim, OM; Matsumoto, Y; Negishi, K; Ogawa, Y; Saiki, M; Sato, EA; Shigeno, Y; Tsubota, K | 1 |
Hamzavi, IH; Mahmoud, BH; Marcus, DV | 1 |
Calistru, PI; Castaing, N; Chernyak, V; Cooper, CA; Dartois, N; Gandjini, H; Milutinovic, S; Strausz, J; Tanaseanu, C; Zolubas, M | 1 |
Hsueh, PR; Lee, PI; Yang, JC | 1 |
Hall, JM; Kahn, MA; Moreland, AA; Moschella, SL; Torske, KR | 1 |
Akachi, S; Kondo, M; Kurokawa, I; Nishii, M; Yamanaka, K | 1 |
Furuse, J; Itabashi, M; Iwamoto, N; Kitagawa, N; Konno, T; Miyazawa, T; Motoori, S; Saisho, H; Saito, S | 1 |
Ozbek, B; Sentürk, A | 1 |
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP | 1 |
Girdhar, A; Girdhar, BK; Kumar, A | 1 |
Iwasawa, MT; Kambe, N; Matsue, H; Ohkusu, K; Ota, R | 1 |
Drokov, MIu; Galstian, GM; Giliazitdinova, EA; Karpova, TI; Katrysh, SA; Kliasova, GA; Marakusha, BI; Tartakovskiĭ, IS | 1 |
Boivin, JF; Jerajani, HR; Setia, MS; Shinde, SS | 1 |
Ghate, SD; Pai, VV; Shetty, VP; Wakade, AV | 1 |
Chong, Y; Chung, HS; Hong, SG; Jeong, SH; Kim, M; Lee, K; Lee, Y; Yong, D | 1 |
Babinchak, T; Cooper, AC; Gardiner, D; Ramirez, JA; Wiemken, T | 1 |
Avison, MB; Gould, VC; Okazaki, A | 1 |
Attia, AM; Bakry, OA | 1 |
Ahn, JY; Chang, CL; Chong, Y; Chung, HS; Hong, SG; Kim, YR; Lee, HS; Lee, K; Park, YJ; Shin, JH; Shin, KS; Uh, Y; Whang, DH | 1 |
Cunha, Mda G; Lockwood, DN | 1 |
Igbinosa, IH | 1 |
Debata, NK; Jena, J; Sahoo, RK; Subudhi, E | 1 |
Dogra, S; Narang, T; Sakia, UN | 1 |
Acuña-Villaorduña, A; Barrionuevo, P; De la Cruz-Luque, C; Domecq, JP; Lazo-Porras, M; Málaga, G; Ponce, OJ; Prokop, LJ; Prutsky, GJ; Tapia, JC; Ugarte-Gil, C | 1 |
Ahuja, M; Darlong, J; Kumar, A; Lavania, M; Nathan, R; Pathak, VK; Sengupta, U; Singh, I; Turankar, RP | 1 |
4 review(s) available for ofloxacin and minocycline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Refractory respiratory tract infections. 6. New problems in refractory respiratory tract infections. c. Chemotherapy of methicillin-resistant Staphylococci infection].
Topics: Anti-Bacterial Agents; Cefmetazole; Cephamycins; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin; Minocycline; Ofloxacin; Oxazines; Penicillin Resistance; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus epidermidis; Tetracyclines | 1987 |
Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; Treatment Outcome | 2011 |
World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Child; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Multibacillary; Leprosy, Paucibacillary; Male; Middle Aged; Minocycline; Mycobacterium leprae; Neglected Diseases; Ofloxacin; Recurrence; Rifampin; Treatment Failure; World Health Organization; Young Adult | 2020 |
17 trial(s) available for ofloxacin and minocycline
Article | Year |
---|---|
Antimicrobial treatment for chronic prostatitis as a means of defining the role of Ureaplasma urealyticum.
Topics: Adult; Aged; Chronic Disease; Humans; Leukocyte Count; Male; Middle Aged; Minocycline; Ofloxacin; Prostatitis; Ureaplasma Infections; Ureaplasma urealyticum | 1993 |
Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Leprosy, Lepromatous; Male; Mice; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Skin | 1996 |
Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 1997 |
Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Combinations; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; Treatment Outcome; World Health Organization | 1997 |
Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Topics: Adolescent; Adult; Animals; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Nude; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1998 |
Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Minocycline; Ofloxacin; Rifampin; Treatment Outcome | 1998 |
A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
Topics: Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Treatment Outcome | 2000 |
Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Vaccines; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Cohort Studies; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Neuritis; Ofloxacin; Rifampin | 2001 |
Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 2004 |
Serological response to chemoprophylaxis in extended contacts in leprosy--a randomized controlled trial.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antibodies, Bacterial; Child; Cohort Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Humans; Immunoglobulin M; Leprostatic Agents; Leprosy; Minocycline; Myanmar; Mycobacterium leprae; Ofloxacin; Rifampin; Risk; Seroepidemiologic Studies; Time Factors | 2008 |
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Female; Gram-Negative Bacterial Infections; Haemophilus Infections; Humans; Levofloxacin; Liver Function Tests; Male; Middle Aged; Minocycline; Ofloxacin; Pneumococcal Infections; Pneumonia, Bacterial; Tigecycline; Treatment Outcome | 2008 |
Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
Topics: Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Female; Haemophilus influenzae; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Moraxella catarrhalis; Multivariate Analysis; Ofloxacin; Pneumonia, Bacterial; Streptococcus pneumoniae; Tigecycline; Treatment Outcome | 2009 |
Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; International Agencies; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Safety; Tigecycline; Treatment Outcome | 2008 |
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Minocycline; Nausea; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Severity of Illness Index; Tigecycline; Treatment Outcome; Vomiting; Young Adult | 2009 |
A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India.
Topics: Adolescent; Adult; Child; Child, Preschool; Clarithromycin; Female; Humans; India; Leprosy, Paucibacillary; Male; Middle Aged; Minocycline; Ofloxacin; Recurrence; Rifampin; Survival Analysis; Treatment Outcome | 2011 |
Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Female; Humans; Infusions, Intravenous; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Tigecycline; Treatment Outcome | 2012 |
94 other study(ies) available for ofloxacin and minocycline
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
The permeation of amphoteric drugs through artificial membranes--an in combo absorption model based on paracellular and transmembrane permeability.
Topics: Caco-2 Cells; Cell Membrane Permeability; Humans; Hydrogen-Ion Concentration; Membranes, Artificial; Molecular Structure; Pharmaceutical Preparations | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin | 1992 |
[Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
Topics: Chlamydia trachomatis; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Humans; In Vitro Techniques; Minocycline; Ofloxacin; Pefloxacin; Roxithromycin; Spiramycin | 1992 |
[Three cases of postpartum infection with methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Adult; Cefmetazole; Drug Therapy, Combination; Female; Humans; Imipenem; Methicillin Resistance; Minocycline; Ofloxacin; Puerperal Infection; Scarlet Fever; Staphylococcal Infections | 1992 |
[Clinical analysis of male urethritis].
Topics: Adolescent; Adult; Child; Gonorrhea; Humans; Japan; Lymphogranuloma Venereum; Male; Middle Aged; Minocycline; Ofloxacin; Penicillins; Quinolones; Retrospective Studies; Sexually Transmitted Diseases; Urethritis | 1991 |
[A case report of spotted fever group rickettsiosis first encountered in Shimane Prefecture, Japan].
Topics: Antibodies, Bacterial; Drug Therapy, Combination; Humans; Japan; Male; Middle Aged; Minocycline; Ofloxacin; Rickettsia; Rickettsia Infections; Tetracyclines | 1990 |
[The clinical effectiveness of OFLX in the treatment of chlamydial pneumonia].
Topics: Adolescent; Adult; Child; Chlamydophila psittaci; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Minocycline; Ofloxacin; Pneumonia; Psittacosis | 1989 |
In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.
Topics: Anti-Infective Agents; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Fleroxacin; Fluoroquinolones; Minocycline; Norfloxacin; Ofloxacin; Quinolones | 1988 |
[Frequency of clinical isolation of glucose non-fermentative gram-negative rods and their susceptibilities to antibacterial agents].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fermentation; Glucose; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Pseudomonas aeruginosa | 1995 |
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline | 1995 |
The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Topics: Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Minocycline; Ofloxacin; Propionibacterium acnes; Staphylococcus epidermidis | 1994 |
[Multicenter study of the in vitro sensitivity of genital mycoplasmas to antibiotics].
Topics: Clindamycin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Female; Humans; In Vitro Techniques; Josamycin; Lymecycline; Male; Minocycline; Mycoplasma; Ofloxacin; Ureaplasma urealyticum; Virginiamycin | 1993 |
The incidence of isolation of methicillin-resistant Staphylococcus aureus (MRSA) strains from skin infections during the past three years (1989-1991).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteriophage Typing; Child; Cilastatin; Coagulase; Colony Count, Microbial; Drug Resistance, Microbial; Humans; Imipenem; Impetigo; Methicillin Resistance; Middle Aged; Minocycline; Ofloxacin; Pressure Ulcer; Staphylococcal Skin Infections; Staphylococcus aureus | 1993 |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1996 |
In vitro and in vivo antichlamydial activities of HSR-903, a new fluoroquinolone antibiotic.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia; Chlamydophila psittaci; Fluoroquinolones; HeLa Cells; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Psittacosis; Quinolones | 1997 |
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Diffusion; Flavobacterium; Humans; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Piperacillin | 1997 |
[High prevalence of leprosy in the Federated States of Micronesia and special project for the elimination].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Micronesia; Minocycline; Ofloxacin; Rifampin | 1997 |
Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocytes; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Lymphocytes; Male; Minocycline; Ofloxacin; Recurrence; Rifampin | 1998 |
Changes in white blood cell counts in men undergoing thrice-weekly prostatic massage, microbial diagnosis and antimicrobial therapy for genitourinary complaints.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Antibiotics, Antineoplastic; Bacterial Infections; Drug Therapy, Combination; Humans; Leukocyte Count; Low Back Pain; Male; Massage; Middle Aged; Minocycline; Ofloxacin; Pain; Pelvic Pain; Prostatitis; Retrospective Studies; Sexual Dysfunction, Physiological; Urinary Retention | 1998 |
[New WHO recommendations for the treatment of leprosy].
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Skin | 1997 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Report of workshop on chemotherapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; World Health Organization | 1998 |
Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community Health Workers; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1999 |
Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clofazimine; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Prednisolone; Rifampin; Secondary Prevention | 1999 |
Single-dose treatment for paucibacillary leprosy; field implications.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cohort Studies; Confidence Intervals; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Secondary Prevention | 1999 |
Histopathological activity in paucibacillary leprosy patients after ROM therapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Granuloma; Humans; Leprosy, Lepromatous; Male; Minocycline; Ofloxacin; Rifampin; Skin | 1999 |
Elimination of leprosy in the federated states of micronesia by intensive case finding, treatment with WHO/MDT and administration of chemoprophylaxis.
Topics: Adolescent; Adult; Chemoprevention; Humans; Leprostatic Agents; Leprosy; Micronesia; Minocycline; Ofloxacin; Rifampin; World Health Organization | 1999 |
Population screening and mass chemoprophylaxis in Kiribati.
Topics: Adolescent; Chemoprevention; Child; Child, Preschool; Communicable Disease Control; Humans; Leprostatic Agents; Leprosy; Mass Screening; Micronesia; Minocycline; Ofloxacin; Patient Care Team; Rifampin | 1999 |
Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands.
Topics: Chemoprevention; Contact Tracing; Drug Therapy, Combination; Leprostatic Agents; Leprosy; Mass Screening; Micronesia; Minocycline; Ofloxacin; Prevalence; Rifampin | 1999 |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Glycogen; Humans; Male; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Plasmids; Urethritis | 2000 |
[Fibrosing alveolitis following Legionella pneumonia].
Topics: Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pulmonary Fibrosis; Pulse Therapy, Drug; Steroids; Treatment Outcome | 2000 |
Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Topics: Adenosine Triphosphate; Biopsy; Clofazimine; Dapsone; DNA, Bacterial; Drug Evaluation; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Treatment Outcome | 1999 |
Leprosy chemoprophylaxis in Micronesia.
Topics: Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Leprostatic Agents; Leprosy; Male; Mass Screening; Micronesia; Minocycline; Ofloxacin; Rifampin; Treatment Outcome | 2000 |
Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; India; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Prognosis; Rifampin; Treatment Outcome | 2000 |
Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Biopsy; Brazil; Child; Cohort Studies; Drug Therapy, Combination; Educational Status; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Selection; Rifampin | 2000 |
Single-dose treatment for single lesion leprosy; histopathological observations.
Topics: Anti-Infective Agents; Drug Therapy, Combination; Granuloma; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; Tetracycline | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Clinical, histopathological and bacteriological investigations in two cases of relapse following ROM treatment.
Topics: Adult; Animals; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Minocycline; Ofloxacin; Recurrence; Rifampin | 2001 |
Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
Topics: Adolescent; Anti-Infective Agents; Drug Therapy, Combination; Extremities; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Borderline; Minocycline; Mycobacterium leprae; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pulse Therapy, Drug; Rifampin; Skin; Treatment Outcome | 2001 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Recurrence; Rifampin | 2002 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2003 |
[A case of pulmonaly bulla infection with Mycobacterium fortuitum].
Topics: Aged; Blister; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Lung Diseases, Interstitial; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Pulmonary Emphysema | 2003 |
[Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Ofloxacin; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2003 |
Susceptibility of mixed infection of Ureaplasma Urealyticum and Mycoplasma Hominis to seven antimicrobial agents and comparison with that of Ureaplasma Urealyticum infection.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Josamycin; Male; Middle Aged; Minocycline; Mycoplasma hominis; Mycoplasma Infections; Ofloxacin; Superinfection; Ureaplasma Infections; Ureaplasma urealyticum | 2003 |
In situ type 1 cytokine gene expression and mechanisms associated with early leprosy progression.
Topics: Adolescent; Adult; Antibodies, Bacterial; Biopsy; Child; Cohort Studies; Cytokines; Female; Gene Expression Regulation, Bacterial; Humans; Leprosy; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; RNA, Viral; Th1 Cells | 2003 |
Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Blood Platelets; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Minocycline; Ofloxacin; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2003 |
Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Clarithromycin; Enoxacin; Epithelial Cells; Erythromycin; Fibroblast Growth Factors; Gingiva; Humans; Integrins; Keratins; Laminin; Lethal Dose 50; Minocycline; Ofloxacin; Proteins; Roxithromycin; Tetracycline | 2004 |
A rare variant of erythema nodosum leprosum: a case report.
Topics: Abscess; Adult; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Macrophages; Male; Melanins; Minocycline; Mycobacterium tuberculosis; Neutrophils; Ofloxacin; Rifampin; Tumor Necrosis Factor-alpha; Vasculitis | 2003 |
[Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].
Topics: Adult; Biopsy; Clarithromycin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Female; Forearm; Hand Dermatoses; Humans; Levofloxacin; Lymphadenitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Ofloxacin; Skin; Skin Diseases, Bacterial; Sporotrichosis; Treatment Outcome | 2004 |
[Clinical study of male urethritis in Oogaki Municipal Hospital].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Chlamydia Infections; Fluoroquinolones; Gonorrhea; Hospitals, Municipal; Humans; Japan; Levofloxacin; Male; Middle Aged; Minocycline; Naphthyridines; Ofloxacin; Sexual Partners; Sexually Transmitted Diseases, Bacterial; Spectinomycin; Urethritis | 2005 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Hypersensitivity; India; Leprosy; Minocycline; Nausea; Ofloxacin; Rifampin; Secondary Prevention; Tuberculosis; World Health Organization | 2004 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Treatment of chronic fatigue syndrome with antibiotics: pilot study assessing the involvement of Coxiella burnetii infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Bacterial; Child; Coxiella burnetii; DNA, Bacterial; Doxycycline; Fatigue Syndrome, Chronic; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Male; Middle Aged; Minocycline; Ofloxacin; Pilot Projects; Polymerase Chain Reaction; Q Fever; Retrospective Studies; Treatment Outcome | 2005 |
Persister studies in leprosy patients after multi-drug treatment.
Topics: Adenosine Triphosphate; Adolescent; Adult; Anti-Bacterial Agents; Colony Count, Microbial; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Skin; Treatment Failure | 2005 |
The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Doxycycline; Luminescence; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Prevotella intermedia; Tetracycline; Tetracyclines | 2006 |
In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Staphylococcus aureus; Streptococcus pneumoniae; Tigecycline; Vancomycin Resistance | 2007 |
[Bilophila wadsworthia isolated from surgical specimens].
Topics: Anti-Bacterial Agents; beta-Lactams; Bilophila; Ciprofloxacin; Clindamycin; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Humans; Japan; Levofloxacin; Minocycline; Ofloxacin; Peritonitis; Postoperative Complications; Specimen Handling; Surgical Wound Infection | 2006 |
[Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
Topics: Aged; Anti-Bacterial Agents; Clofazimine; Cystamine; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin; Time Factors; Treatment Outcome | 2007 |
Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
Topics: Adolescent; Adult; Aging; Cohort Studies; DNA, Bacterial; Erythema Nodosum; Female; Humans; Leprosy; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin; Risk Factors; Time Factors | 2007 |
A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Models, Biological; Monte Carlo Method; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Tigecycline | 2008 |
[New antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactams; Daptomycin; Ertapenem; Humans; Ketolides; Minocycline; Ofloxacin; Tigecycline; Virginiamycin | 2008 |
Large subcutaneous abscesses caused by Mycobacterium fortuitum infection.
Topics: Abscess; Adult; Anti-Bacterial Agents; Female; Humans; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Subcutaneous Tissue | 2008 |
Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lymphoma, Mantle-Cell; Male; Middle Aged; Minocycline; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sepsis; Stem Cell Transplantation; Tigecycline | 2008 |
The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blepharitis; Drug Therapy, Combination; Female; Fluorometholone; Glucocorticoids; Humans; Hyaluronic Acid; Male; Meibomian Glands; Microscopy, Confocal; Middle Aged; Minocycline; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Tears; Treatment Outcome | 2009 |
Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Granuloma Annulare; Humans; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 2009 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Clinical-pathological conference: case 3.
Topics: Adult; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infections; Leishmaniasis; Leprostatic Agents; Leprosy, Multibacillary; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Palate; Prednisone; Rifampin; Strongyloidiasis; Treatment Outcome | 2010 |
Topical treatment with incision and antiseptic may prevent the severity of Japan spotted fever.
Topics: Aged; Anti-Infective Agents, Local; Ceftriaxone; Erythema; Female; Fever; Humans; Minocycline; Ofloxacin; Povidone-Iodine; Rickettsia Infections; Severity of Illness Index; Treatment Outcome | 2010 |
[A case of mucosa-associated lymphoid tissue lymphoma with penicillin allergy successfully treated with levofloxacin, minomycin and rabeprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Biopsy; Drug Hypersensitivity; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Minocycline; Ofloxacin; Penicillins; Rabeprazole | 2010 |
Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Thienamycins; Tigecycline | 2010 |
Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
Topics: Anti-Bacterial Agents; Bacterial Load; Bacterial Typing Techniques; Erythromycin; Humans; Legionella; Legionellosis; Levofloxacin; Macrophages; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Ofloxacin; Serotyping; Tigecycline; Time Factors | 2011 |
Maximum growth temperature test for cutaneous Mycobacterium chelonae predicts the efficacy of thermal therapy.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Hyperthermia, Induced; Male; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Neutrophil Infiltration; Ofloxacin; Prednisolone; Skin Diseases, Bacterial; Treatment Outcome | 2012 |
[A case of legionellesis pneumonia verified by isolation of Legionella pneumophila serogroup 1 from bronchoalveolar lavage fluid treated with levofloxacine and tigecycline].
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pneumonia, Bacterial; Tigecycline; Treatment Outcome | 2011 |
Clinical, bacteriological and histopathological study of 62 referral relapse cases between Jan 2004 and Dec 2009 at the Foundation for Medical Research, Mumbai.
Topics: Academies and Institutes; Adult; Aged; Biomedical Research; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Recurrence; Referral and Consultation; Rifampin; Risk Factors; Skin; Time Factors; Treatment Outcome; Young Adult | 2011 |
Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital.
Topics: Anti-Infective Agents; Hospitals; Korea; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Ciprofloxacin; Gene Expression; Genes, MDR; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Stenotrophomonas maltophilia; Tetracycline | 2013 |
Histoid leprosy: case report.
Topics: Aged; Atrophy; Dermis; Epidermis; Humans; Leprostatic Agents; Leprosy; Male; Minocycline; Ofloxacin; Rifampin | 2012 |
Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
Topics: Anti-Infective Agents; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Republic of Korea; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Compliance; Rifampin; World Health Organization | 2012 |
Prevalence and detection of antibiotic-resistant determinant in Salmonella isolated from food-producing animals.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalothin; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Food Microbiology; Foodborne Diseases; Goats; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Polymerase Chain Reaction; Salmonella; Salmonella Infections; South Africa; Tetracycline | 2015 |
Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Burns; Ceftazidime; Ceftriaxone; Cilastatin; Clavulanic Acid; Colistin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genetic Variation; Humans; Imipenem; Minocycline; Netilmicin; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Pseudomonas aeruginosa; Tigecycline | 2015 |
Persistent serpentine supravenous hyperpigmented eruption in lepromatous leprosy after minocycline.
Topics: Adult; Anti-Bacterial Agents; Clofazimine; Humans; Hyperpigmentation; Leprostatic Agents; Leprosy, Lepromatous; Male; Minocycline; Ofloxacin | 2015 |
Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India.
Topics: Clofazimine; Drug Therapy, Combination; Hospitals; Humans; India; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; World Health Organization | 2020 |